Exploring the Role of Tau Proteins in Alzheimer’s Disease from Typical Functioning MAPs to Aberrant Fibrillary Deposits in the Brain
Authors:
- 1 September 2023
- book chapter
- Published by Springer Nature
- p. 321-349
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathiesHuman Molecular Genetics, 2012
- Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3β by TideglusibJournal of Biological Chemistry, 2012
- A Phase II Study of Sagopilone (ZK 219477; ZK-EPO) in Patients With Breast Cancer and Brain MetastasesClinical Breast Cancer, 2011
- Sequence-independent Control of Peptide Conformation in Liposomal Vaccines for Targeting Protein Misfolding DiseasesJournal of Biological Chemistry, 2011
- The acetylation of tau inhibits its function and promotes pathological tau aggregationNature Communications, 2011
- Immunotherapy for Alzheimer’s diseaseJournal of Internal Medicine, 2010
- Acetylation of Tau Inhibits Its Degradation and Contributes to TauopathyNeuron, 2010
- Resveratrol directly targets COX‐2 to inhibit carcinogenesisMolecular Carcinogenesis, 2008
- The GSK3 hypothesis of Alzheimer’s diseaseJournal of Neurochemistry, 2007
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006